You are viewing the site in preview mode
Skip to main content
| | Effect size (95% CI) | p |
|---|
EF (%) |
Age (year) | -0.1 (-0.2;0) | 0.006 |
Hypertension | -2.8 (-4.8;-0.8) | 0.006 |
DT (msec) |
- | - | - |
E/e’ |
Age (year) | 1 (1;1) | < 0.001 |
BMI (kg/m2) | 1 (1;1) | 0.044 |
Hypertension | 0.8 (0.7;0.9) | 0.002 |
Diabetes | 0.8 (0.7;1) | 0.021 |
- Results based on linear mixed models. p < 0.05 was considered statistically significant. 95% CI, 95% confidence interval; EF, ejection fraction; DT, deceleration time; E/ e’, ratio of early diastolic flow peak velocity of the mitral valve (E) and early diastolic peak velocity of mitral valve annulus (e’). Model 2 was adjusted for age, body mass index, hypertension, diabetes mellitus, hyperlipidaemia, current smoking, major adverse cardiac events, previous chemotherapy as fixed effects
